Highlighting a New Potential Target in Stroke: Immunoreceptor NKG2D

Highlighting a New Potential Target in Stroke: Immunoreceptor NKG2D

Bibliographic Details
Main Authors:	Josef Anrather, Kimberly Marks
Format:	Article
Language:	English
Published:	Wiley 2023-06-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	Editorials CD8+ T cells NK cells NKG2D stroke
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.123.030482

Similar Items

NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
by: Jagoda Siemaszko, et al.
Published: (2021-06-01)

NKG2D Polymorphism in Melanoma Patients from Southeastern Spain
by: Lourdes Gimeno, et al.
Published: (2019-03-01)

Targeting NKG2DL with Bispecific NKG2D–CD16 and NKG2D–CD3 Fusion Proteins on Triple–Negative Breast Cancer
by: Polina Kaidun, et al.
Published: (2023-08-01)

Largely preserved functionality after the combined loss of NKG2D, NCR1 and CD16 demonstrates the remarkable plasticity of NK cell responsiveness
by: Vanna Imširović, et al.
Published: (2023-07-01)

Molecular bases for the regulation of NKG2D ligands in cancer
by: Leticia eHuergo-Zapico, et al.
Published: (2014-03-01)

The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology
by: Florencia Secchiari, et al.
Published: (2022-12-01)

NKG2D: A Master Regulator of Immune Cell Responsiveness
by: Felix M. Wensveen, et al.
Published: (2018-03-01)

INHIBITION OF THE NKG2D ACTIVATING RECEPTOR EXPRESSION ON CYTOTOXIC LYMPHOCYTES BY RECOMBINANT MICA PROTEIN
by: E. V. Abakushina, et al.
Published: (2017-01-01)

Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response
by: Richard Baugh, et al.
Published: (2020-12-01)

Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells
by: Jagoda Siemaszko, et al.
Published: (2023-10-01)

Expression of NKG2D Receptors in CD3+ and CD56+ Cells in Blood Samples of Pre-eclampsia Patients and the Effect of Silymarin on Their Activity in Vitro
by: Ali Reza Andalib, et al.
Published: (2022-04-01)

A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression
by: Trever T Greene, et al.
Published: (2016-11-01)

Anti-NKG2D single domain-based antibodies for the modulation of anti-tumor immune response
by: Adeline Raynaud, et al.
Published: (2021-01-01)

POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE
by: E. A. Shulenina, et al.
Published: (2017-08-01)

Differential Effects of Histone Deacetylases on the Expression of NKG2D Ligands and NK Cell-Mediated Anticancer Immunity in Lung Cancer Cells
by: Haeryung Cho, et al.
Published: (2021-06-01)

NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain
by: Gia-Gia T. Hò, et al.
Published: (2020-06-01)

Responsiveness to Influenza Vaccination Correlates with NKG2C-Expression on NK Cells
by: Peggy Riese, et al.
Published: (2020-06-01)

The Human Soluble NKG2D Ligand Differentially Impacts Tumorigenicity and Progression in Temporal and Model-Dependent Modes
by: Anthony V. Serritella, et al.
Published: (2024-01-01)

Autophagy-mediated NKG2D internalization impairs NK cell function and exacerbates radiation pneumonitis
by: Ruiqing Wang, et al.
Published: (2023-11-01)

Isolation of a cytolytic subpopulation of extracellular vesicles derived from NK cells containing NKG7 and cytolytic proteins
by: Miriam Aarsund, et al.
Published: (2022-09-01)

The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
by: Ge Tan, et al.
Published: (2023-08-01)

The Impact of Cytomegalovirus Infection on Natural Killer and CD8+ T Cell Phenotype in Multiple Sclerosis
by: Valentina Perri, et al.
Published: (2024-02-01)

CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients
by: Lourdes Gimeno, et al.
Published: (2021-01-01)

Endothelial cells express NKG2D ligands and desensitize antitumor NK responses
by: Thornton W Thompson, et al.
Published: (2017-12-01)

NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells
by: Marta Ibáñez-Navarro, et al.
Published: (2023-10-01)

Co-expression of IL-21-Enhanced NKG2D CAR-NK cell therapy for lung cancer
by: Yan Zhang, et al.
Published: (2024-01-01)

IDO1 can impair NK cells function against non-small cell lung cancer by downregulation of NKG2D Ligand via ADAM10
by: Xin Fang, et al.
Published: (2022-03-01)

Radiosensitization effect by HDAC inhibition improves NKG2D-dependent natural killer cytotoxicity in hepatocellular carcinoma
by: Yu-Fan Liu, et al.
Published: (2022-09-01)

IL-15 induced bystander activation of CD8+ T cells may mediate endothelium injury through NKG2D in Hantaan virus infection
by: Xiyue Zhang, et al.
Published: (2022-12-01)

Porcine UL-16 Binding Protein 1 Is Not a Functional Ligand for the Human Natural Killer Cell Activating Receptor NKG2D
by: Kevin J. Lopez, et al.
Published: (2023-11-01)

Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer
by: Jack G. Fisher, et al.
Published: (2022-11-01)

Impact of NKG2D Signaling on Natural Killer and T‐Cell Function in Cerebral Ischemia
by: Christina David, et al.
Published: (2023-06-01)

SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway
by: Daria Bortolotti, et al.
Published: (2020-08-01)

KLF4-mediated upregulation of the NKG2D ligand MICA in acute myeloid leukemia: a novel therapeutic target identified by enChIP
by: Reem Alkhayer, et al.
Published: (2023-05-01)

Dual Targeting of Glioblastoma Cells with Bispecific Killer Cell Engagers Directed to EGFR and ErbB2 (HER2) Facilitates Effective Elimination by NKG2D-CAR-Engineered NK Cells
by: Anne Kiefer, et al.
Published: (2024-01-01)

Lenalidomide improves NKG2D-based CAR-T cell activity against colorectal cancer cells invitro
by: Mahdi Zarei, et al.
Published: (2023-10-01)

β-catenin attenuation leads to up-regulation of activating NKG2D ligands and tumor regression in BrafV600E-driven thyroid cancer cells
by: Minjing Zou, et al.
Published: (2023-07-01)

Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2Cnull Human Immunodeficiency Virus-Infected Individuals
by: Emilie M. Comeau, et al.
Published: (2019-03-01)

Size Matters: The Functional Role of the CEACAM1 Isoform Signature and Its Impact for NK Cell-Mediated Killing in Melanoma
by: Iris Helfrich, et al.
Published: (2019-03-01)

Preclinical characterization of Pan-NKG2D ligand-binding NKG2D receptor decoys
by: Peter B. Rupert, et al.
Published: (2024-04-01)